Back
Theriva Biologics Stock Price Chart
Sponsored
TOVX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
TOVX
Theriva Biologics
Last Price:
1.28
Seasonality Move:
28.41%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight buying pressure.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.28 | Sell |
20-day SMA: | 1.57 | Sell |
50-day SMA: | 1.82 | Sell |
200-day SMA: | 6.59 | Sell |
8-day EMA: | 1.33 | Sell |
20-day EMA: | 1.48 | Sell |
50-day EMA: | 2.07 | Sell |
200-day EMA: | 6.06 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 36.9 | Sell |
Chaikin Money Flow: | 1854 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.27 - 1.85) | Sell |
Bollinger Bands (100): | (1.49 - 5.51) | Sell |
Theriva Biologics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 1.28 while TOVX 8-day simple moving average is 1.28, which is a Sell signal.
- The stock price of TOVX is 1.28 while Theriva Biologics 20-day SMA is 1.57, which makes it a Sell.
- Theriva Biologics 50-day simple moving average is 1.82 while TOVX share price is 1.28, making it a Sell technically.
- TOVX stock price is 1.28 and Theriva Biologics 200-day simple moving average is 6.59, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
46
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a Sell
The current Theriva Biologics [TOVX] share price is $1.28. The Score for TOVX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics Stock Info
Market Cap:
3.56M
Price in USD:
1.28
Share Volume:
35.23K
Theriva Biologics 52-Week Range
52-Week High:
17.11
52-Week Low:
1.22
Sell
46
Theriva Biologics (TOVX)
is a Sell
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?
The Theriva Biologics stock price is 1.28 USD today. -
Will TOVX stock go up or go down?
Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators -
Is Theriva Biologics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is overvalued.
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 1.28 while TOVX 8-day exponential moving average is 1.33, which is a Sell signal.
- The stock price of TOVX is 1.28 while Theriva Biologics 20-day EMA is 1.48, which makes it a Sell.
- Theriva Biologics 50-day exponential moving average is 2.07 while TOVX share price is 1.28, making it a Sell technically.
- TOVX stock price is 1.28 and Theriva Biologics 200-day simple moving average is 6.06, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
- TOVX Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Theriva Biologics is a Sell
- Theriva Biologics Relative Strength Index (RSI) is 36.9, which suggest Theriva Biologics is oversold
- The Bollinger Bands (25) for Theriva Biologics is (1.27 - 1.85), which suggest Theriva Biologics is a Sell
- The Bollinger Bands (100) for Theriva Biologics is (1.49 - 5.51), which suggest Theriva Biologics is a Sell
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.